4275 Executive Square,5th Floor
La Jolla , CA, 92037

Rank

Rank Universe
0 97

Summary

The fund seeks capital appreciation in the long term by investing in companies outside the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team calculates the estimated intrinsic value of a company on the basis of factors such as a company&rsquo More

Link

Directors

Dec 14, 2023
  • Gregory Bishop
  • Robert M. Fitzgerald
  • Craig Wainscott
  • Jeff Busby
  • Oliver Murray

Chief Compliance Officer

  • Roberta Loubier

Fund Manager(s)

Price

  • $ 22.47 ( +0.21 )
    Nov 5, 2024
    Last Close
  • Net Assets
  • $754.3M
    Feb 26, 2024
  • Holding
  • 72
    Aug 27, 2024
    More

  • 52-Week High/Low
  • $23.39 - $18.32
  • Turnover
  • 14.4%
  • Expense Ratio
  • 0.93%

Company Name

Holding

Northern Inst Fds 3.15 %
Takeda Pharmaceutical Co Ltd. 3.06 %
Alibaba Group Holding Ltd. 2.69 %
Sanofi 2.55 %
Heineken Holding N.V. 2.51 %
SAP SE 2.32 %
Taiwan Semiconductor Manufacturing Co., Ltd. 2.25 %
Henkel AG & Co. KGaA 2.21 %
Rolls-Royce Holdings PLC 2.19 %
Intesa Sanpaolo S.p.A. 2.16 %
More 2.16 %

Documents

Prospectus

Annual Reports

Performance

YTD

3.5%

3 Year

21.26%

5 Year

34.47%

Best

56.23%

1999

Worst

-37.18%

2008

Alpha

BIIEX S&P 500

Chart +